NCT06981325 2026-03-11CEMI-firstInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 2 Recruiting34 enrolled
NCT06585410 2026-02-25Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaRegeneron PharmaceuticalsPhase 3 Recruiting369 enrolled